Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy

被引：45
|
作者：
Visentin, Andrea [1 ,2 ]
Compagno, Nicolo [1 ,2 ]
Cinetto, Francesco [1 ,2 ]
Imbergamo, Silvia [1 ]
Zambello, Renato [1 ,2 ]
Piazza, Francesco [1 ,2 ]
Semenzato, Gianpietro [1 ,2 ]
Trentin, Livio [1 ,2 ]
Agostini, Carlo [1 ,2 ]
机构：
[1] Univ Padua, Sch Med, Dept Med, Hematol & Clin Immunol Branch, I-35100 Padua, Italy
[2] Ctr Eccellenza Ric Biomed Avanzata, Venetian Inst Mol Med, Milan, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷 / 12期
关键词：
CLL; infections; secondary hypogammaglobulinemia; hypogammaglobulinemia; immunoglobulin replacement therapy; HYPOGAMMAGLOBULINEMIA; COMPLICATIONS; GUIDELINES; DIAGNOSIS; SECONDARY; DISEASE;
D O I：
10.3324/haematol.2015.126763
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E515 / E518
页数：4
相关论文
共 50 条
  • [31] Genomic complexity identifies patients with agressive chronic lymphocytic leukemia.
    Malek, Sami N.
    Ouillette, Peter
    Erba, Harry
    Saddler, Chris
    Jakubowiak, Andrzej
    Kaminski, Mark
    Shedden, Kerby
    Kujawski, Lisa
    BLOOD, 2007, 110 (11) : 151A - 151A
  • [32] PBSC mobilization and immune selection in patients with chronic lymphocytic leukemia.
    Scimè, R
    Indovina, A
    Santoro, A
    Musso, M
    Olivieri, A
    Tringali, S
    Crescimanno, A
    Montanari, M
    Felice, R
    Catania, P
    Mariani, G
    Leoni, P
    Majolino, I
    BLOOD, 1998, 92 (10) : 307B - 307B
  • [33] Safety and efficacy of Ibrutinib in Indian patients with chronic lymphocytic leukemia.
    Gogia, Ajay
    Sharma, Atul
    Gupta, Ritu
    Rani, Lata
    Mallick, Saumyaranjan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] DINACICLIB AND DINACICLIB GLUCURONIDE PHARMACOKINETICS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.
    Zhao, Y.
    Ling, Y.
    Kolli, S.
    Poi, M.
    Schaaf, L. J.
    Johnson, A. J.
    Byrd, J. C.
    Jones, J. A.
    Phelps, M. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S95 - S95
  • [35] Epstein-Barr virus in patients with chronic lymphocytic leukemia.
    Tsimberidou, AM
    Keating, MJ
    Bueso-Ramos, C
    Kurzrock, R
    BLOOD, 2005, 106 (11) : 598A - 598A
  • [36] Differential expression profile of the proteome and transcriptome in aggressive and indolent chronic lymphocytic leukemia.
    Liu, YT
    Rassenti, LZ
    Shen, ZX
    Chuang, HY
    Briggs, SP
    Kipps, TJ
    Carson, D
    BLOOD, 2005, 106 (11) : 594A - 595A
  • [37] Cryptococcal infections in two patients receiving ibrutinib therapy for chronic lymphocytic leukemia
    Stankowicz, Matthew
    Banaszynski, Megan
    Crawford, Russell
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (03) : 710 - 714
  • [38] Pentostatin combination therapy for untreated B-chronic lymphocytic leukemia.
    Kay, NE
    Lin, T
    Call, T
    Jelinek, DF
    Bone, ND
    Dewald, GW
    Heerema, NA
    Tschumper, R
    Smith, L
    Geyer, SM
    Byrd, JC
    BLOOD, 2003, 102 (11) : 676A - 676A
  • [39] Gene expression profile analysis for class prediction and discovery in chronic lymphocytic leukemia.
    Zent, CS
    Chen, JB
    Evans, RB
    Schichman, SA
    BLOOD, 2000, 96 (11) : 749A - 749A
  • [40] Bacterial Colonization in Patients with Chronic Lymphocytic Leukemia and Factors Associated with Infections and Colonization
    Korona-Glowniak, Izabela
    Grywalska, Ewelina
    Grzegorczyk, Agnieszka
    Rolinski, Jacek
    Glowniak, Andrzej
    Malm, Anna
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (06)
12345